Bryan Spann
Neurology · Los Angeles, CANPI 1679500912
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $1,589 of the $1,914 with a category attached, or 83.0%. Every reported general payment came from a single manufacturer, Eisai Inc..
Across 12 payments — averaging $159.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eisai Inc.$2K
Across 91 payments — averaging $19,655 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eisai Inc.$1.1M
- Eli Lilly$242K
- Biogen$230K
- Novartis$132K
- AbbVie$71K
- Genentech, Inc.$57K
What the payments were for
- Travel & lodging$1,58983%
- Food & beverage$32517%
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eisai Inc. | 12 | $1,914 |
How this compares
$1,914 in reported general payments places this provider in the 55th percentile of 1,996 neurology providers in California.
Other neurology in Los Angeles
- Perry ShiehLos Angeles$2.4M
- David LiebeskindLos Angeles$1.9M
- John SternLos Angeles$999K
- Jeffrey CummingsLos Angeles$918K
- Alan RapoportLos Angeles$808K
- Alon AvidanLos Angeles$505K
- Mark LewLos Angeles$450K
- Dawn EliashivLos Angeles$364K
- Richard LewisLos Angeles$309K
- Margaret BurnettLos Angeles$293K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.